Published On: Wed, Oct 19th, 2016

Mead Johnson Nutrition Company (NYSE:MJN) Analyst Review


A number of investment brokers have recently updated their price targets on shares of Mead Johnson Nutrition Company (NYSE:MJN).

Most recent broker ratings

10/12/2016 – Mead Johnson Nutrition Company had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 95 price target on the stock.

10/06/2016 – Mead Johnson Nutrition Company had its “outperform” rating reiterated by analysts at BMO Capital Markets. They now have a USD 96 price target on the stock.

09/27/2016 – Mead Johnson Nutrition Company had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 85 price target on the stock.

09/08/2016 – Mead Johnson Nutrition Company had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 103 price target on the stock.

08/24/2016 – UBS began new coverage on Mead Johnson Nutrition Company giving the company a “neutral” rating. They now have a USD 90 price target on the stock.

08/03/2016 – Mead Johnson Nutrition Company was upgraded to “outperform” by analysts at CLSA. They now have a USD 96 price target on the stock.

07/29/2016 – Mead Johnson Nutrition Company was downgraded to “hold” by analysts at Societe Generale. They now have a USD 95 price target on the stock.

07/29/2016 – Mead Johnson Nutrition Company had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 105 price target on the stock.

07/13/2016 – Mead Johnson Nutrition Company was upgraded to “neutral” by analysts at Bank of America Merrill Lynch.

02/17/2016 – Mead Johnson Nutrition Company had its “hold” rating reiterated by analysts at Deutsche Bank. They now have a USD 76 price target on the stock.

02/01/2016 – Mead Johnson Nutrition Company had its “neutral” rating reiterated by analysts at Nomura. They now have a USD 88 price target on the stock.

01/08/2016 – Mead Johnson Nutrition Company was downgraded to “underperform” by analysts at Credit Agricole.

10/26/2015 – Susquehanna began new coverage on Mead Johnson Nutrition Company giving the company a “neutral” rating. They now have a USD 75 price target on the stock.

05/05/2015 – Mead Johnson Nutrition Company was upgraded to “hold” by analysts at Zacks.

01/27/2015 – Mead Johnson Nutrition Company had its “hold” rating reiterated by analysts at Morgan Stanley. They now have a USD 104 price target on the stock.

The share price of Mead Johnson Nutrition Company (NYSE:MJN) was up +0.63% during the last day of trading, with a day high of 80.65. 1347233 shares were traded during the last session.

The stock’s 50 day moving average is 79.57 and its 200 day moving average is 84.54. The stock’s market capitalization is 14.79B. Mead Johnson Nutrition Company has a 52-week low of 65.53 and a 52-week high of 94.40.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.